Results 81 to 90 of about 92,867 (160)

Beyond QSARs: Quantitative Knowledge-Activity Relationships (QKARs) for enhanced drug toxicity prediction. [PDF]

Toxicol Sci
Li T, Qu Y, Chen A, Thakkar S, Li D, Tong W.   +5 more
europepmc   +1 more source

Imidazole Alkaloids Epiisopilosine and Epiisopiloturine Attenuate Acetaminophen-Induced Liver Toxicity in Mice via Autophagy Modulation and Anti-Inflammatory Effects. [PDF]

J Biochem Mol Toxicol
de Oliveira AP, Pacheco G, Lopes ALF, da Silva Araujo AK, de Sousa Chaves L, de Araújo S, de Sousa Lima EB, Alves EHP, Queiroz-Junior CM, Teixeira MM, Costa VV, Souza JMT, Barros AB, de Araujo Sousa PS, Rocha JA, Araújo AJ, Filho JDBM, Véras LMC, Vasconcelos DFP, Medeiros JVR.   +19 more
europepmc   +1 more source

Preclinical approaches to studying liver and kidney fibrosis: models and methodologies. [PDF]

Front Pharmacol
Tiwari A, Singh S, Sharma RK, Kumar S.
europepmc   +1 more source

Hepatoprotective Effect of Ethanolic Extract of Cnestis ferruginea Roots on Carbon tetrachloride-Induced Liver Damage in Male Rats

Journal of Applied Sciences and Environmental Management
Hepatoprotection or antihepatotoxicity is the ability of an agent or chemical to prevent damage to the liver. These hepatoprotective agents mitigate the liver injury caused by the hepatotoxic agents.
E. O. Okoro
doaj  

Human Leukocyte Antigen (<i>HLA</i>) Signatures and Idiosyncratic Drug-Induced Liver Injury. [PDF]

Int J Mol Sci
Onaciu A, Grama A, Agoșton Ș, Mititelu A, Mariş B, Ştefănescu H, Pop TL.   +6 more
europepmc   +1 more source

Decoding liver injury in cystic fibrosis: How to tell drug-induced liver injury from cystic fibrosis liver disease. [PDF]

World J Gastroenterol
Lee J, Yekula A, Wexler A, Zhuang W, Elangovan A, Rosario J, Burger P, Ramaraju G, Addissie B, Lim N, Narkewicz MR, Twohig P.   +11 more
europepmc   +1 more source

Comprehensive review of tujia "Lian" medicinal botanical drugs: traditional classification system, phytochemical, and pharmacological profile. [PDF]

Front Pharmacol
Kuang N, Mao Y, Aamer M, Jiang P, Huang F, Yang Y, Sheng W, Peng C, Wang W, Li B.   +9 more
europepmc   +1 more source

Drug-Induced Liver Injury Associated With the Angiotensin II Receptor Blocker Losartan in a 59-Year-Old Woman With Hypertension: A Case Report. [PDF]

Am J Case Rep
Al-Ajaj A, Melki W.
europepmc   +1 more source

Exploring the toxic mechanism of excessive intake of naringin on drug-induced liver injury using network toxicology and experiment validation strategy. [PDF]

BMC Pharmacol Toxicol
Ding Y, Yu T, He J, Peng C, Wang X, Huang J.   +5 more
europepmc   +1 more source

Self-assembled PEGylated nanoparticles based on Elafibranor derivative 3d for the treatment of metabolic dysfunction-associated steatohepatitis. [PDF]

J Biol Eng
Yu J, Wang J, Li S, Bai S, Wang X, Ban Y, Zhang S, Yu Y, Liu J, Liu Z, Galons H, Zhang Y, Yu P, Xiang C, Teng Y.   +14 more
europepmc   +1 more source